ASX Runners: Zelira, Linq, Dalaroo & Osteopore Lead Gains
Zelira Therapeutics rockets 184% on $50m autism drug deal, while Linq Minerals and Dalaroo Metals surge on gold, copper and Greenland rare earths. Discover the week's top ASX performers.
Category : Search result: Zelira Therapeutics
Ex-Woodside CEO Peter Coleman leads PYC Therapeutics
Former Woodside Energy boss Peter Coleman takes helm at PYC Therapeutics following board crisis and managing director's brief resignation. Key leadership change aims to restore investor confidence.
Page 1 of 1